You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

AstraZenca’s antibody cocktail Evusheld receives MHRA authorisation

The Medicines & Healthcare products Regulatory Agency (MHRA) has authorised AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) – the first antibody combination for pre-exposure prophylaxis against COVID-19 licensed in the UK.